AnGes, Inc.
AnGes, Inc. (AMGXF) Financial Performance & Income Statement Overview
Review AnGes, Inc. (AMGXF) income statement, balance sheet, and cash flow reports with annual and quarterly breakdowns.
AnGes, Inc. (AMGXF) Income Statement & Financial Overview
Explore comprehensive income reports for AnGes, Inc. AMGXF, broken down by year and quarter.
| Metric | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 |
|---|---|---|---|---|
| Revenue | $169.24M | $172.00M | $124.00M | $234.01M |
| Cost of Revenue | $113.05M | $111.00M | $85.00M | $158.00M |
| Gross Profit | $56.19M | $61.00M | $39.00M | $76.01M |
| Gross Profit Ratio | $0.33 | $0.35 | $0.31 | $0.32 |
| R&D Expenses | $789.92M | $855.00M | $683.00M | $1.27B |
| SG&A Expenses | $521.72M | $1.27B | $1.29B | $1.43B |
| Operating Expenses | $1.31B | $2.13B | $1.97B | $2.71B |
| Total Costs & Expenses | $1.42B | $2.24B | $2.06B | $2.87B |
| Interest Income | $1.07M | $1.52M | $0.00 | $663000.00 |
| Interest Expense | $0.00 | $0.00 | $0.00 | $25.44M |
| Depreciation & Amortization | $2.65M | $842.50M | $777.00M | $876.92M |
| EBITDA | -$1.23B | -$1.23B | -$1.16B | -$1.79B |
| EBITDA Ratio | -$7.30 | -$7.13 | -$9.33 | -$7.63 |
| Operating Income | -$1.26B | -$2.07B | -$1.94B | -$2.63B |
| Operating Income Ratio | -$7.42 | -$12.02 | -$15.60 | -$11.24 |
| Other Income/Expenses (Net) | $17.99M | -$18.51B | -$1.71B | $984.37M |
| Income Before Tax | -$1.24B | -$20.58B | -$3.65B | -$1.65B |
| Income Before Tax Ratio | -$7.31 | -$119.64 | -$29.41 | -$7.04 |
| Income Tax Expense | $10.39M | $394.00M | $9.00M | $29.52M |
| Net Income | -$1.25B | -$20.97B | -$3.66B | -$1.68B |
| Net Income Ratio | -$7.37 | -$121.93 | -$29.48 | -$7.16 |
| EPS | -$3.98 | -$75.80 | -$15.06 | -$7.54 |
| Diluted EPS | -$3.98 | -$75.80 | -$15.06 | -$7.54 |
| Weighted Avg Shares Outstanding | $313.13M | $276.67M | $242.79M | $222.29M |
| Weighted Avg Shares Outstanding (Diluted) | $313.13M | $276.67M | $242.79M | $222.29M |
Over the past four quarters, AnGes, Inc. demonstrated steady revenue growth, increasing from $234.01M in Q2 2024 to $169.24M in Q1 2025. Operating income reached -$1.26B in Q1 2025, maintaining a consistent -742% margin over recent quarters. Despite fluctuations in R&D and SG&A expenses, EBITDA remained robust at -$1.23B, reflecting operational efficiency. Net income rose to -$1.25B, with EPS at -$3.98. Disciplined expense management helped sustain profitability, highlighting solid overall financial performance.
Unlock 25+ Years of Financial Data
Get access to extended historical data, advanced metrics, and more with our premium plan